MedPath

Fosap

Brand Name: Fosap

Generic Name: Fosaprepitant (as Dimeglumine)

Active
Registration Number

DR-XY48536

Dosage Form

Lyophilized Powder for Solution for IV Infusion

Issuance Date

February 2, 2023

Expiry Date

December 22, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength150 mg
Packaging10 mL-capacity USP Type I tubular glass vial sealed with grey bromobutyl rubber stopper and flip-off seal (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Monitored Release (Correction)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Fosaprepitant (as Dimeglumine)Active
Monograph: fosaprepitant (as dimeglumine)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform